Cargando…
Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370362/ https://www.ncbi.nlm.nih.gov/pubmed/37501683 http://dx.doi.org/10.1158/2767-9764.CRC-22-0373 |
_version_ | 1785077923820077056 |
---|---|
author | Senosain, Maria-Fernanda Zou, Yong Patel, Khushbu Zhao, Shilin Coullomb, Alexis Rowe, Dianna J. Lehman, Jonathan M. Irish, Jonathan M. Maldonado, Fabien Kammer, Michael N. Pancaldi, Vera Lopez, Carlos F. |
author_facet | Senosain, Maria-Fernanda Zou, Yong Patel, Khushbu Zhao, Shilin Coullomb, Alexis Rowe, Dianna J. Lehman, Jonathan M. Irish, Jonathan M. Maldonado, Fabien Kammer, Michael N. Pancaldi, Vera Lopez, Carlos F. |
author_sort | Senosain, Maria-Fernanda |
collection | PubMed |
description | Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention. SIGNIFICANCE: This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice. |
format | Online Article Text |
id | pubmed-10370362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for Cancer Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-103703622023-07-27 Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness Senosain, Maria-Fernanda Zou, Yong Patel, Khushbu Zhao, Shilin Coullomb, Alexis Rowe, Dianna J. Lehman, Jonathan M. Irish, Jonathan M. Maldonado, Fabien Kammer, Michael N. Pancaldi, Vera Lopez, Carlos F. Cancer Res Commun Research Article Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention. SIGNIFICANCE: This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice. American Association for Cancer Research 2023-07-26 /pmc/articles/PMC10370362/ /pubmed/37501683 http://dx.doi.org/10.1158/2767-9764.CRC-22-0373 Text en © 2023 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. |
spellingShingle | Research Article Senosain, Maria-Fernanda Zou, Yong Patel, Khushbu Zhao, Shilin Coullomb, Alexis Rowe, Dianna J. Lehman, Jonathan M. Irish, Jonathan M. Maldonado, Fabien Kammer, Michael N. Pancaldi, Vera Lopez, Carlos F. Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title | Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title_full | Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title_fullStr | Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title_full_unstemmed | Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title_short | Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness |
title_sort | integrated multi-omics analysis of early lung adenocarcinoma links tumor biological features with predicted indolence or aggressiveness |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370362/ https://www.ncbi.nlm.nih.gov/pubmed/37501683 http://dx.doi.org/10.1158/2767-9764.CRC-22-0373 |
work_keys_str_mv | AT senosainmariafernanda integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT zouyong integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT patelkhushbu integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT zhaoshilin integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT coullombalexis integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT rowediannaj integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT lehmanjonathanm integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT irishjonathanm integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT maldonadofabien integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT kammermichaeln integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT pancaldivera integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness AT lopezcarlosf integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness |